AntineoplasticsPneumonia, acquired drug resistance and lack of efficacy: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1946卷 / 1期

关键词：

D O I：

10.1007/s40278-023-34665-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：64 / 64

相关论文

共 50 条

[1] AntineoplasticsMyelotoxicity, acquired drug resistance and lack of efficacy: 4 case reports
Reactions Weekly, 2020, 1818 (1) : 40 - 40
[2] AntineoplasticsAcneiform rash, acquired drug resistance and lack of efficacy: 4 case reports
Reactions Weekly, 2022, 1906 (1) : 58 - 58
[3] Antifungals/antineoplasticsInfections, acquired drug resistance and lack of efficacy: 11 case reports
Reactions Weekly, 2022, 1925 (1) : 55 - 55
[4] Multiple drugsDrug intolerance, cytopenias, acquired drug resistance and lack of efficacy: 2 case reports
Reactions Weekly, 2025, 2046 (1) : 313 - 313
[5] AntineoplasticsAcquired drug resistance and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1903 (1) : 46 - 46
[6] AntineoplasticsVomiting, drug resistance and lack of efficacy: 2 case reports
Reactions Weekly, 2021, 1878 (1) : 71 - 71
[7] AntineoplasticsAcquired drug resistance and lack of efficacy : 2 case reports
Reactions Weekly, 2023, 1963 (1) : 58 - 58
[8] Isoniazid/PrednisoloneActive tuberculosis, acquired drug resistance and lack of efficacy: 5 case reports
Reactions Weekly, 2024, 2028 (1) : 263 - 263
[9] Multiple drugsGastroenteritis, dermatitis, acquired drug resistance and lack of efficacy: 8 case reports
Reactions Weekly, 2023, 1949 (1) : 306 - 306
[10] Immunotherapy/lenvatinibAcquired drug resistance and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1913 (1) : 255 - 255

← 1 2 3 4 5 →